



This is the published version 
 
Ghazawi, Ibtisam, Cutler, Samuel J., Low, Pauline, Mellick, Albert S. and 
Ralph, Stephen J. 2005, Inhibitory effects associated with use of modified 
Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter 
assays and implications for analysis of ISGs, Journal of interferon and 



























JOURNAL OF INTERFERON & CYTOKINE RESEARCH 25:92–102 (2005)
© Mary Ann Liebert, Inc.
Inhibitory Effects Associated with Use of Modified Photinus
pyralis and Renilla reniformis Luciferase Vectors in Dual
Reporter Assays and Implications for Analysis of ISGs
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and STEPHEN J. RALPH
ABSTRACT
Luciferase reporter constructs are widely used for analysis of gene regulation when characterizing promoter
and enhancer elements. We report that the recently developed codon-modified Renilla luciferase construct in-
cluded as an internal standard for cotransfection must be used with great caution with respect to the amount
of DNA transfected. Also, the dual-luciferase reporter vectors encoding Photinus pyralis firefly or Renilla reni-
formis luciferase showed a linear increase in dose-response with increasing amounts of transfected DNA, but
at higher levels of transfected DNA, a reduction in expressed levels of luciferase activity resulted. In addition,
treatment with type I interferon (IFN) was found to significantly reduce levels of P. pyralis firefly and Renilla
luciferase activity. In contrast, cells transfected with a green fluorescent protein (GFP) reporter construct
showed no significant IFN-associated change. The reduction in luciferase activity resulting from IFN treat-
ment was not due to IFN-mediated cytotoxicity, as no change in cellular propidium iodide (PI) staining was
observed by flow cytometry. IFN treatment did not alter the levels of firefly luciferase activity in cell culture
supernatants or the luciferase mRNA levels determined by quantitative real-time RT-PCR analysis. Based on
these results, it is probable that the IFN-induced reduction in levels of luciferase activity detected in reporter
assays occurs via a posttranscriptional mechanism. Thus, it is important to be aware of these complications
when using luciferase reporter systems in general or for analyzing cytokine-mediated responsive regulation
of target genes, particularly by the type I IFNs.
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INTRODUCTION
REPORTER GENE ASSAYS ARE ROUTINELY USED in studieswhose aim is the functional characterization of putative
promoter or enhancer regions. Three popular reporter proteins
used for this purpose include green fluorescent protein (GFP),
Photinus pyralis firefly luciferase, and Renilla reniformis lu-
ciferase. The latter two assays represent the most widely used
reporter enzymes available for transcriptional regulation stud-
ies. GFP is used for investigating the localization dynamics and
characteristics of gene expression. GFP assays are simple and
allow monitoring of kinetics of GFP and GFP-tagged molecules
within living cells. By comparison, luminescence assays with
transiently expressed firefly luciferase provide for convenient
and sensitive linear readout for accurate quantification over a
wide range of enzyme concentrations. R. reniformis luciferase
is commonly used as a control for transfection efficiency and
is often included with firefly luciferase in gene reporter assays.
Reporter constructs are generally used with the assumption
that the activity of the encoded reporter proteins is not directly
affected by the agents tested or the treatment conditions. As a
result, the effects that various test treatments and parameters
might have in altering the reporter output are rarely considered.
Recent reports, however, have described some complications
resulting from the effect of biologically active compounds on
the activity of certain reporter constructs. For example, Kogai
et al.(1) demonstrated that retinoic acids induce increased ex-
pression of the modified firefly luciferase reporter gene (luc)
from the pGL3-basic vector (Promega Corp., Madison, WI).
This is despite the claims of the manufacturer that suggest that
because the pGL3-basic construct contains a minimal promoter
region, it should be suitable as a control in transfection-based
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gene regulation studies. In addition, an effect of androgen on
the Renilla luciferase reporter expression has been described
when assayed in the context of the herpes simplex virus (HSV)-
thymidine kinase promoter.(2) Both studies describe the cau-
tionary requirements imposed by such technical difficulties in
interpreting gene regulatory data.
Interferons (IFNs), which include type I IFNs (IFN- and
IFN-) and type II IFN (IFN-), are widely studied multifunc-
tional cytokines with considerable biomedical significance. The
ability of type I IFNs to inhibit cell proliferation and to pro-
duce cytotoxic effects on cancer cells has resulted in their use
as anticancer therapies (reviewed in refs. 3, 4). In addition, IFNs
can induce apoptosis in tumor cells, making them important
therapeutics for clinical use in treating cancers.(5,6) IFNs are
also potent antiviral agents, resulting in their application in the
therapy of viral hepatitis.(7–10) The multifunctional effects of
IFNs on cells are mediated via intracellular signaling pathways,
activation of which regulates expression of IFN-stimulated
genes (ISGs).(11,12) Several studies have reported that IFNs can
also affect gene expression at the posttranscriptional level (re-
viewed in refs. 13, 14). For instance, it has been demonstrated
that IFN- treatment causes inhibition of cellular protein syn-
thesis.(15)
We have investigated the effect of IFN treatment on the com-
monly used reporter genes, GFP, P. pyralis firefly luciferase,
and Renilla luciferase. Here we report that (1) type I IFN in-
hibits the levels of expressed activity produced from both the
firefly and Renilla luciferase reporter vectors in transient trans-
fection reporter assays, (2) the repression in levels of lucifer-
ase activity by type I IFN is likely to be mediated through a
posttranscriptional mechanism, (3) the recently developed
codon-modified Renilla luciferase construct (Promega Corp.),
when included as an internal standard for cotransfection, must
be used with great caution with respect to the amount of DNA
transfected, and (4) both of the dual-luciferase reporter vectors
show a linear range in dose-response with increasing amounts
of transfected DNA but, if used in excess, will cause inhibition
in expressed levels of luciferase activity. Our observations are
particularly relevant to the ready use of commercially available
systems, such as the Dual-Glo reporter assay (Promega Corp.),
as these are gaining in popularity because of their simplicity
and ease of application.
MATERIALS AND METHODS
Cell culture and treatment
The human melanoma cell line SK-MEL-28 (American Type
Culture Collection [ATCC] Rockville, MD) was grown in
RPMI 1640 medium supplemented with 10% heat-inactivated
fetal bovine serum (FBS). The human cervical adenocarcinoma
cell line HeLa S3 (ATCC) was grown in DMEM supplemented
with 10% FBS. Cells either were left without stimulation or
were treated with 1000 IU/ml IFN-, IFN-, or IFN-, unless
otherwise indicated.
Construction of reporter plasmids
The pGL3-basic luciferase reporter vector containing luc,
a modified form of the gene encoding firefly (P. pyralis) lu-
ciferase, was used to prepare the ISG15-luc construct as a pos-
itive control for type I IFN stimulation. The oligonucleotide de-
sign as described in Wong et al.,(16) which was based on the
canonical ISG15 IFN-stimulated response element (ISRE) site
was modified at the overhangs to enable use of the restriction
enzymes, KpnI and BglII, compatible for insertion into the
pGL3 vector. Complementary oligonucleotides were annealed
at equal molar ratios and cloned into the pGL3-basic vector (5-
CATGCCTCGGGAAAGGGAAACCGAAACTGAAGCC-3
and antisense 5-GATCGGCTTCAGTTTCGGTTTCCCTT-
TCCCGAGGCATGGTAC-3). The underlined sequence con-
tains the ISRE from the ISG15 gene promoter and was used to
regulate firefly luciferase in ISG15-luc. The pEF-luc(17) con-
struct contained the luc gene derived from the pGL3-basic
vector and then cloned into the pEFMCIneopAN9(16,17) vector
via KpnI and XbaI restriction enzyme sites downstream from
the EF-1 promoter. The phRL-SV40 vector (Promega Corp.)
contains a modified luciferase gene derived from R. reniformis.
The pBOS-H3-N-GFP expression vector encoding H3 histone
tagged with GFP was a kind gift from Dr J. Neuzil (School of
Health Science, Griffith University). This vector contains the
histone H3-GFP gene with a 23-residue linker under the con-
trol of the EF-1 promoter.(18)
Cell transfection
Transfection complexes were formed using a ratio of 1 g
vector DNA (pGL3-basic, ISG15-luc, pEF-luc, phRL-SV40, or
pBOS-H3-N-GFP plasmid) to 1 l Lipofectamine 2000 (Invit-
rogen Corp., San Diego, CA) or Fugene 6 (Roche Applied Sci-
ence, Nutley, NJ) for 20–40 min. Then, 50 l DNA/transfec-
tion reagent mix was added to 50 l serum-free Opti-MEM I
medium (Invitrogen Corp.) using a procedure based on the man-
ufacturer’s instructions, without the presence of antibiotics. 
SK-MEL-28 and HeLa S3 cells were cultured for 24 h prior to
transfection at a density of 7.5  103 and 1.5  104 cells, re-
spectively, per well, in a 96-well tissue culture plate with
150–200 l complete medium/well. Culture medium was re-
placed by the addition of the 100 l transfection complex. At
3–4 h after transfection, the medium was replaced with 200
l fresh complete medium. At 20–24 h posttransfection, cells
either were left untreated or were stimulated with 1000 IU/ml
IFN- (Biogen, Cambridge, MA) IFN-2b, or IFN- (Hoff-
man-La Roche, Basel, Switzerland), unless otherwise indicated,
and incubated for a further 16 h.
For the dose-response, time course, and flow cytometry ex-
periments, SK-MEL-28 cells were first seeded in 10-cm dishes
at approximately 80% confluency and were transfected with 
12 g plasmid DNA using 24 l Lipofectamine 2000 (50%
w/v). At 18 h posttransfection, cells were subcultured into 24 
2 ml/well plates at approximately 40% confluence per well, and
after a further 6 h (24 h posttransfection), they were treated with
IFN.
Assay of luciferase activity
Following IFN stimulation and at the times indicated, cell
lysates or supernatants or both were prepared and assayed for
luciferase activity. Cells in wells of a 24-well plate were de-
tached by incubation in 30 l 90 M EDTA/phosphate-buffered
saline (PBS) (37°C, 5 min) and were then lysed at ambient tem-
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perature by the addition of 70 l lysis buffer (37.5 mM Tris-
phosphate, pH 8, 15% glycerol, 1.5% Triton-X-100, 1.5 g/l
bovine serum albumin [BSA], and 3 mM DTT). For measure-
ment of luciferase activity, a modified procedure based on the
Dual-Glo luciferase reporter assay protocol was used. Thus, for
the firefly luciferase assay, 100 l of reaction buffer was added
to the cell lysates in each well. The reaction buffer contained
40 mM Tricine, pH 8.0, 16 mM magnesium chloride, 0.26 mM
EDTA, pH 8.0, and 60 mM DTT, as well as 0.6 mM coenzyme
A (CoA), 1 mM beetle luciferin and 1 mM ATP, which were
added to the reaction buffer immediately before use and just
before measurement of luciferase activity. For the time course
and relative titration experiments, cells were lysed in 50–100
l PBS in situ in the wells of the 96-well or 24-well microtiter
culture dishes by two successive freeze (80°C)-thaw cycles.
For those titration experiments where the effects of phRL-
SV40 Renilla reporter plasmid on firefly luciferase were ex-
amined, the first reaction buffer (for firefly luciferase mea-
surements) comprised 40 mM Tricine, pH 8.0, 16 mM
magnesium chloride, 260 M EDTA, pH 8.0, and 60 mM DTT,
as well as 0.6 mM CoA, 1 mM beetle luciferin, 1 mM ATP,
15% glycerol, 0.1% Tergitol-NP9, and 1.5 g/l BSA. For the
second reaction buffer (for Renilla luciferase measurements),
the following components were prepared as a 3  concentrated
Stop-Glow stock solution: 22.5 mM sodium pyrophosphate,
22.5 mM sodium acetate, pH 5.9, 30 mM CDTA, 600 mM so-
dium sulfate, 9 mM thiourea, 0.01% Tween-20, and 1 M coe-
lenterazine (Promega). This was diluted one third by the addi-
tion to the first reaction volume containing firefly luciferase.
Luciferase activity was measured in a luminometer (FLUOstar
OPTIMA, BMG Labtechnologies, Melbourne, Australia).
Replicates (3–4 wells) were used for each sample, and each ex-
periment was repeated at least twice.
Propidium iodide (PI) staining and 
fluorometric assays
pBOS-H3-N-GFP transfectants were harvested 16 h after
IFN stimulation. Cells were resuspended at 3  104 cells/0.45
ml PBS buffer containing 1% FBS and were stained with PI at
a final concentration of 5 g/ml within 15 min prior to sample
analysis. The green (454 nm) fluorescence and PI fluorescence
of cells were measured by fluorescence cytometry using a 
FACScalibur (Becton Dickinson, Sydney, Australia).
RNA preparation and quantitative RT-PCR analysis
Total RNA was extracted from 8.8  104 cells after 12 h of
IFN treatment and isolated using NucleoSpin RNA II minispin
columns (Machery-Nagel, Düren, Germany). For cDNA syn-
thesis, random decamers and the MMLV RNase H reverse
transcriptase (RT) (Promega Corp.) were used (42°C, 45 min)
in a final 20-l reaction volume. Amplification of specific tar-
gets from 2 l of a 1:5 dilution of the cDNA pool was carried
out using the SYBR Green I iQ SUPERMIX (Bio-Rad Labo-
ratories, Hercules, CA). PCR product in real-time was detected
using the IQ iCycler System (Bio-Rad Laboratories). Specific
primers used were: Luc forward, 5-CATCTTCGAC-
GCAGGTGTC-3; reverse, 5-GACTGGCGACGTAATCCA-
C-3; ISG15 forward, 5-GTGCAGGACGACCTGTTCT-3;
reverse, 5-GATTCATGAACACGGTGCTC-3; ISG54 for-
ward, 5-TGCAACCTACGGCCTATCTA-3; reverse, 5-CA-
GGTGACCACACTTCTGATT-3; 18SrRNA forward, 5-CT-
TAGAGGGACAAGTGGCG-3; reverse, 5-ACGCTGAGC-
CAGTCAGTGTA-3. The specific annealing for Luc, 18Sr-
RNA, and ISG15 primers was determined to be 59°C. For the
ISG54 primer, this was set at 61°C. Cycling conditions were
95°C for 2 min, 95°C for 30 sec, 59°C/61°C for 1 min, 72°C
for 30 sec  45. The specificity of PCR product obtained at end
point was confirmed by melt curve analysis and 10% PAGE in
1  TBE.
Data analysis and statistics
Statistical analysis was performed using version 12 SPSS
software (SPSS Inc., Chicago, IL). Data are reported as
means  SE. Independent t-test or ANOVA (more than two
groups) was used to determine the significance of the differ-
ences between the means (p  0.05). Methods for analysis of
Q-PCR data have been described previously.(19,20) Comparative
values for cycle threshold at linearity (Ct) were obtained rela-
tive to the reference 18SrRNA (Ct(21)). The fold difference
(2CT) between treated and untreated cells was determined
to be significant if the Ct values for test and Ct values for
control were statistically significantly different.
RESULTS
IFN-/ treatment of cells transfected with luciferase
reporter constructs causes reduced expression of
luciferase activity
The IFN-sensitive SK-MEL-28 and HeLa S3 cells were tran-
siently transfected with the high expression reporter vector,
pEF-Luc, to determine if IFN treatment affected the resulting
activity levels of firefly luciferase (P. pyralis) produced in cell
transfectants. The results (Fig. 1A,B) revealed that after 16 h
of IFN treatment, a significant reduction (30%–60%) in lu-
ciferase activity was observed in both cell lines in response to
1000 IU/ml of either IFN- or IFN-, whereas the same con-
centration of IFN- (1000 IU/ml) showed no effect. With the
SK-MEL-28 cells, the extent of inhibition caused by IFN-
treatment was more substantial (60%) than that resulting from
IFN- treatment (30%).
Next, dose-response curves with type I IFN treatment were
analyzed over a range of IFN- concentrations for their effect
(Fig. 1C). The results revealed that increasing amounts of 
IFN- from 25–1600 IU/ml were increasingly effective at re-
ducing the luciferase activity detected in the cell transfectants.
Amounts as low as 25 IU/ml IFN- were sufficient to produce
a reduction of 20% in luciferase activity compared with the
levels obtained in control transfected cells. Given the extent of
repression in levels of luciferase activity obtained with the
higher IFN concentrations, a concentration of 500 IU/ml 
IFN- was selected for subsequent experiments.
The results of a time course of IFN treatment of transfec-
tants over several days (Fig. 1D) showed no significant reduc-
tion in luciferase activity between the IFN--treated and un-
treated cells occurring within the initial 8 h after addition of
IFN. However, a more rapid reduction (over 30% below con-
trol) in levels of firefly luciferase activity occurred by 16–24 h
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in the IFN-treated population, followed by a steady decline in
parallel with the rate of decay occurring in the control cells.
Studies were not carried out beyond 72 h because luciferase ac-
tivity was continuing to decline at a similar steady rate in both
treatment and control groups at this time (Fig. 1D).
Type I IFN also reduced R. reniformis luciferase activity ex-
pressed in transfectants. To investigate the influence of IFN
treatment on Renilla luciferase expression, SK-MEL-28 cells
were transiently transfected with the codon-modified Renilla
luciferase reporter vector, phRL-SV40, where the luciferase
gene is controlled by the SV40 large T promoter. As with the
pEF-luc firefly luciferase transfectants (Fig. 2), 16 h of IFN
treatment caused significant inhibition in luciferase activity in
response to 1000 IU/ml of either IFN- or IFN-, whereas no
significant effect of 1000 IU/ml IFN- was noted. The magni-
tudes of the reduction in Renilla luciferase activity caused by
IFN- or IFN- were not as marked as for pEF-luc but were
about 18%–20%.
To test whether the type I IFN-mediated inhibition of ex-
pressed luciferase activity would be compensated by normaliz-
ing the data against the values obtained from the Renilla lucif-
erase in a dual-luciferase reporter cotransfection assay (data not
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FIG. 1. Inhibitory effect of type I IFNs on expressed levels of firefly luciferase reporter activity. After transfection with 1 g
pEF-luc construct, 0.75–1.5  104 cells in wells of a 96-well plate were incubated with or without 1000 IU/ml IFN-, IFN-,
or IFN- for 16 h as indicated. (A) SK-MEL-28 cells. (B) HeLa S3 cells. (C) IFN- dose-response curve of SK-MEL-28 trans-
fectants treated for 16 h. (D) SK-MEL-28 transfectants treated for different times up to 72 h with or without the presence of 500
IU/ml IFN-. Firefly luciferase activity in cell lysates was measured by luminometry, and the results are given in relative light
units (RLU) as mean values  SE.
shown), the percentages of IFN-mediated reduction in firefly
and Renilla luciferase activities were calculated and compared
with the untreated controls. IFN- treatment caused an ap-
proximately 40% reduction in firefly luciferase activity and a
19% reduction in Renilla luciferase activity. IFN- treatment
led to an approximately 30% reduction in firefly luciferase ac-
tivity and an 18% reduction in Renilla luciferase activity. Based
on this analysis, the percentage reduction in Renilla luciferase
activity was lower than that observed for firefly luciferase.
Hence, data normalization with this control would have only
partially compensated for the differential influence of IFN treat-
ment on these reporter activities and would, therefore, have led
to the results being compromised.
Initial IFN-induced reduction of luciferase reporter
gene activity in transfected cells did not result from
cytotoxic effects of IFN on these cells
It was possible that the initial effect of type I IFN in reduc-
ing the levels of firefly luciferase activity might have resulted
from IFN-induced death of the transfectants. Hence, cytotoxi-
city assays were undertaken to analyze the effects of IFN treat-
ment of cells over this period. Initial studies to assess this pos-
sibility were carried out by monitoring the luciferase activity
present in culture supernatants after transiently transfecting the
pEF-luc vector into SK-MEL-28 cells and treating the trans-
fectants with IFN-. Assays based on the release of reporter
enzymes have been used previously to provide an indication of
membrane perforation and cell death initiated either by cell-
mediated cytotoxicity or by complement-mediated killing.(22)
IFN- treatment did not cause increased release of luciferase
activity. On the contrary, the luciferase activity assayed in cul-
ture supernatants of untreated cells was significantly greater at
24–48 h post-IFN treatment compared with that of the IFN--
treated cells (Fig. 3). In fact, the levels of luciferase activity de-
tected in the supernatants were directly proportional to the lev-
els detected in the cells (results not shown). Hence, the results
indicated that the changes in luciferase expression mediated by
IFN- were not caused by any cytotoxic effect compromising
cell membrane permeability.
Reduction in luciferase reporter gene expression in
transfected cells treated with IFN is not the result of
IFN affecting the level of reporter gene transcription
To determine if the IFN-mediated inhibition of firefly lucif-
erase activity was the result of an effect of IFN on transcrip-
tion, causing reduced levels of luciferase mRNA expression, 
Q-PCR analysis was conducted. IFN-–inducible activity was
confirmed with cells transfected using the type I IFN-inducible
ISG15-luc vector construct (Fig. 4A,B). Next, total RNA was
isolated from SK-MEL-28 cells that had been transiently trans-
fected with pEF-Luc and either maintained in culture or treated
with 500 IU/ml IFN- for 12 h. Ct values were obtained and
normalized using 18S rRNA as reference. After comparison
with controls, the activity of IFN on the cells was validated by
the large fold increase detected in endogenous ISG15 and
ISG54 gene expression (Fig. 4D). However, no significant dif-
ference was detected in the Ct values for pEF-luc expression
levels between the transfectants treated or not with IFN (Fig.
4D). Thus, IFN- did not significantly affect luciferase mRNA
levels at the 12 h time point after treatment, indicating that the
IFN--mediated reduction in luciferase levels of activity was
unlikely to be the result of transcriptional regulation of the lu-
ciferase genes.
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FIG. 2. Inhibitory effects of type I IFN on expressed levels
of Renilla luciferase activity. SK-MEL-28 cells (4  104/well)
were cultured in a 24  2 ml plate 24 h before they were tran-
siently transfected with 10 ng Renilla luciferase reporter vector
phRL-SV40 plus 500 ng pGL3-basic vector using 1 l Lipo-
fectamine 2000. At 24 h posttransfection, medium was replaced
with fresh complete medium with or without 1000 IU/ml IFN-
, IFN-, or IFN- for a further 16 h before measuring the lev-
els of luciferase activity in cell lysates. Results are presented in
relative light units (RLU) as mean values  SE.
FIG. 3. The inhibitory effect of IFN- is not associated with
increased levels of luciferase activity released by cells. SK-
MEL-28 cells transfected with pEF-luc, as outlined in Materi-
als and Methods, were subcultured into 24  2 ml-well plates
at 4  104 cells/well. At 6 h after subculturing, medium was
replaced with a volume of 360 l fresh complete medium with
or without added IFN- (500 IU/ml) for additional times up to
48 h as indicated. Then, cell culture supernatants were har-
vested, and the luciferase activity was measured. Results are
presented in relative light units (RLU) as mean values  SE.
GFP expression levels detected by green fluorescence
in transfectants are not significantly affected by 
IFN treatment
GFP, either by itself or fused to another protein, has com-
monly been used as a reporter system for expression analysis
(reviewed in ref. 23). Fluorescence microscopy and flow cy-
tometry analysis of GFP expression provide a method for eval-
uating transfection efficiencies and gene expression at the sin-
gle-cell level. To determine if treatment with type I IFN af-
fected GFP expression, SK-MEL-28 cells were transiently
transfected with the histone H3-GFP recombinant expression
vector. In this vector, the gene encoding H3-GFP is controlled
by the EF-1 promoter, the same promoter present in the pEF-
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FIG. 4. IFN- induced ISG expression but did not affect the levels of luciferase transcript detected by real-time PCR. Type I
IFN induction of ISG15-luc transfected into SK-MEL-28 (A) or HeLa S3 (B) cells was analyzed as outlined for Figure 1 and in
Materials and Methods using 1 g DNA and incubated with or without 1000 IU/ml IFN- for 16 h. Next, cell extracts were pre-
pared, and levels of luciferase activity were measured. (C and D) Levels of endogenous ISG15, ISG54, and luciferase mRNA
expression were determined by preparing cDNA and analysis by real-time PCR. SK-MEL-28 cells at 80% confluency were trans-
fected with pEF-luc construct as described in Materials and Methods for 10-cm dishes. At 18 h posttransfection, cells were sub-
cultured into 6-well dishes and were treated or not with 500 IU/ml IFN- for a further 12 h before extracting total RNA. (C)
Specificity of the reaction was analyzed by SDS-PAGE of DNA products from the end point of real-time PCR and were visual-
ized by ethidium bromide staining. M, molecular weight markers. (D) Fold induction of ISG15, ISG54, and luciferase gene ex-
pression by IFN-, determined from real-time PCR results. All graphically presented results show the mean values  SE.
luc vector used to examine the effects of type I IFNs on fire-
fly luciferase expression. For the GFP experiments, transfected
cells either were left untreated or were stimulated with 500
IU/ml IFN- or 1000 IU/ml IFN-. Conditions of transfection
were optimized for this experiment by using HeLa S3 cells as
targets and visually counting the percentage of cells expressing
GFP. The results from fluorescence cytometric analysis of GFP
fluorescence activity at 16 h after IFN treatment indicated no
significant differences in the mean levels (in fluorescence in-
tensities) between the populations of IFN-stimulated vs. un-
treated control cells (results not shown).
A second set of experiments aimed at determining whether
the type I IFN mediated reduction in pEF-luc firefly luciferase
resulted from induced cell death or other cytotoxic effect was
carried out. In this case, PI uptake into transfectants was ana-
lyzed. PI is an early indicator of compromised cell viability, in
which case it stains the intracellular nucleic acids and can be
sensitively detected by flow cytometry.(24,25) No significant dif-
ference was observed in the percentage of PI-positive cells as-
sessed after 16 h of IFN- or IFN- treatment (results not
shown). In addition, no significant difference was detected in
either forward or side scatter profiles of the same cell samples
analyzed by flow cytometry (results not shown). Changes in
these latter two measurements are also indicators of cellular
apoptosis (as decreased cell size and increased cell granularity,
respectively.(24,25) Thus, our results indicated that type I IFN
treatment did not significantly affect the cell viability over the
16 h time period.
Titration of luciferase reporter vectors revealed
inhibitory effects occurring at high levels
As many transfection and reporter assays typically use be-
tween 1 and 2 g of luciferase reporter DNA, this amount was
initially tested in our cotransfection assays to examine gene ac-
tivity with respect to the reference reporter included as control
(phRL-SV40, encoding a modified Renilla luciferase). How-
ever, it rapidly became apparent that the use of the modified
Renilla vector at these levels caused severe inhibitory effects
when cotransfected with different firefly luciferase reporter
constructs. To examine this further, titration studies were per-
formed whereby fixed amounts of either of two different fire-
fly luciferase constructs (ISG15-luc or pEF-luc) were cotrans-
fected with increasing amounts of the Renilla vector DNA. The
results with the 96-well microtiter or 24  2 ml-well plate for-
mats for cell transfection used in this study showed that the in-
hibitory effect with increasing amounts of the Renilla vector
became quite marked with DNA levels above 40–100 ng (Fig.
5). For these studies, the IFN-inducible constructs ISG15-luc
vector or pEF-luc vector was transfected into SK-MEL-28 cells.
The ISG15-luc transfected cells were also treated (or not) with
IFN to examine the effect of increasing concentrations of DNA
on the levels of inducible expression. The signals from both
ISG15-luc and pEF-luc were then examined with respect to in-
troducing increasing amounts of the control/reference vector,
Renilla phRL-SV40, which was also cotransfected into the cells.
The results with the ISG15 reporter (Fig. 5A) revealed that in-
creasing amounts of Renilla vector over the range 1 to 100 ng
in the 24  2 ml/well plate format produced increased output
of Renilla luciferase signal without affecting the firefly lucif-
erase activity levels. However, further increases in levels of Re-
nilla vector above 100 ng caused an inhibitory effect, severely
reducing the output signals from the ISG15-luc firefly and Re-
nilla luciferase reporters regardless of whether or not cells were
treated with IFN (Fig. 5A).
Similar, albeit not as marked, inhibition also resulted when
the pEF-luc firefly luciferase construct (Fig. 5B) was tested in
the 96-well microtiter plate format. In this titration experiment,
the output from the Renilla luciferase vector increased over the
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FIG. 5. Effect of increasing levels of Renilla vector on lu-
ciferase reporter activity. (A) SK-MEL-28 cells in wells of a
24-well plate were cotransfected with 2 g ISG15-luc and dif-
ferent amounts of phRL-SV40 as indicated. IFN--treated sam-
ples included 1000 IU/ml for 16 h. Mean values  SE from
normalized results of two repeated experiments are shown. (B)
SK-MEL-28 cells grown in a 96-well plate were cotransfected
with 400 ng pEF-luc and different amounts of phRL-SV40, as
indicated, per well. Luminescence was measured at 40 h after
transfection. Results are presented as the mean values  SE
(n  6). pEF-luc, m  0.140  0.131, r2  0.063 slope not sig-
nificantly different from zero (p  0.05, by regression analy-
sis); Renilla, m  1.067  0.090, r2  0.893; slope signifi-
cantly different from zero (p  0.0001, by regression analysis).
Transept indicates threshold level of DNA (40 ng) above which
the relationship between signal and DNA becomes nonlinear.
range 1–40 ng of cotransfected Renilla DNA. However, the out-
puts from either cotransfected pEF-luc firefly luciferase or Re-
nilla luciferase were reduced when the levels of Renilla vector
DNA used for transfection went above 40 ng. Thus, cotrans-
fecting Renilla and firefly luciferase vectors at too high a level
of input DNA can impede the resulting level of enzyme activ-
ity expressed from both vectors in dual reporter assays, inde-
pendent of the nature of the promoter regulating the luciferase
genes.
Inclusion of pGL3-basic vector DNA as carrier in
cotransfection luciferase reporter assays does not
prevent inhibition resulting from use of excessive
levels of reporter vector DNA
To determine if the reduction in reporter activity detected
with increasing amounts of transfected DNA was caused by
changes in the ratio of transfection reagent to total DNA (Fig.
5), further studies were carried out. Thus, titration assays with
the cotransfected reporters were performed in 96-well microtiter
plates whereby constant amounts of total DNA were maintained
(400 ng) using the pGL3-basic vector DNA as a carrier. For
the experiment, the level of Renilla was fixed at 4 ng, and pEF-
luc was titrated over a range of 2.5 to 400 ng. The results (Fig.
6) of this experiment revealed that the use of a carrier to stan-
dardize the amount of total DNA transfected helped overcome
variability in the assay. This can be seen by the 40%–50% re-
duction in error in the data recorded when comparing the re-
spective slopes of the graphs in Figure 5B with those in Figure
6. Furthermore, the results in Figure 6 revealed a direct linear
relationship between increased luciferase activity expressed and
increased input amount of DNA, up to 200 ng in this case for
the test vector, pEF-luc. When amounts of pEF-luc vector ex-
ceeded 200 ng, however, the levels of luciferase activity ex-
pressed from both the Renilla control and the pEF-luc reporter
vector were reduced (Fig. 6). Thus, it is important to closely
monitor the DNA dose-response relationship when using these
gene reporter vectors to ensure that the amount transfected into
cells is within the linear range, or erroneous results will be ob-
tained.
DISCUSSION
With their commercial availability and convenience, use of
dual-luciferase reporter enzyme systems is becoming wide-
spread, and they are increasingly used in studies of gene regu-
lation in mammalian cells. The results reported here suggest
that the activities of the modified firefly and Renilla luciferase
are both inhibited by IFN-/ (type I IFNs) treatment in re-
porter assays (Fig. 1 and 2). This finding has significant im-
plications for the interpretation of data in studies using these
reporter assay systems. Analysis of expression from a trans-
fected vector expressing encoded histone H3-GFP by fluores-
cent activity over similar time periods indicated no significant
differences in the levels of expression between IFN-treated and
untreated cells (results not shown). Thus, histone H3-GFP gene
expression as measured by fluorescence levels is not sensitive
to type I IFN in the same manner as observed for the luciferases.
This result would indicate that GFP-based reporter vectors
might be the preferred method for the study of IFN-responsive
genes and their regulation. However, it has been found that the
sensitivity of reporter assays involving GFP are limited by the
long-term stability of GFP(26) and other problems associated
with high levels of background autofluorescence exhibited by
cells at the same emission wavelength as that of GFP.(27)
The value of luciferase reporter constructs is that they gen-
erate strong signals and have a large dynamic range, able to de-
tect very low to very high levels of induced expression above
background. The results of this study suggest that data collected
after luciferase reporter construct transfection assays should be
considered within the context of the effects of the biologic test
agent or cytokine used. Several luciferase constructs should be
employed, and consistent results and induction in response to
the test agent should be used as the basis for further study. Based
on our data, it is recommended that for a 96-well plate format,
one should maintain the levels of Renilla plasmid at 2–5 ng, as
this provides sufficient signal of Renilla luciferase as a refer-
ence reporter while clearly remaining below the level of lucif-
erase inhibition (Fig. 5B). For reporter test plasmids, the opti-
mal level should be that which lies on the linear part of the
curve (	200 ng) (Fig. 6). When transfecting cells in formats
other than 96-well plates, it is recommended to increase the
amount of plasmid reporter DNA in proportion to the target cell
number.
The inhibitory effect of type I IFN detected in the present
study with the firefly luciferase reporter would not have been
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FIG. 6. Effect of increasing levels of firefly vector on lucif-
erase reporter activity. SK-MEL-28 cells grown in a 96-well
microtiter plate were cotransfected with 4 ng phRL-SV40 and
different amounts of pEF-luc (as indicated). The pGL3-basic
vector DNA was used as carrier to maintain the total amount
of transfected DNA constant at 400 ng. Luminescence was mea-
sured at 40 h after transfection. Results are presented as the
mean values  SE (n  6). pEF-luc, m  0.774  0.072, r2 
0.774 slope significantly different from zero (p  0.05, by re-
gression analysis); Renilla, m  0.089  0.041, r2  0.122;
slope significantly different from zero (p  0.05, by regression
analysis). Transept indicates threshold level of DNA (200 ng)
above which the relationship between signal and DNA becomes
nonlinear.
compensated by the use of the R. reniformis luciferase control
vector because the two vectors were affected to a different ex-
tent. As a result, standardizing the data in this manner would
have produced inaccurate or misleading results when attempt-
ing to study gene regulatory elements. This situation would be-
come even more important when studying a promoter that is
only weakly responsive to type I IFNs. Clearly, continued use
of luciferase in such situations as the ISG15 promoter (Fig.
4A,B) is appropriate where the effects of IFN are large and in-
duction above background is readily discerned. Where IFN in-
duction is small, it may be possible to reduce the incubation
times with IFN-/ to 8 h, as no significant type I IFN-asso-
ciated luciferase inhibition was observed at this time in the time
course experiment of IFN treatment (Fig. 1D).
The type I IFN-induced reduction in luciferase activity was
not the result of cytotoxic effects of IFN. It is known that IFN
treatment can cause upregulation of genes involved in stress re-
sponse and apoptosis.(28) However, our results revealed no sig-
nificant difference in the percentage of PI staining at 16 h de-
tected in the IFN-treated vs. control SK-MEL-28 melanoma
cells (results not shown). This is consistent with findings from
other studies, where it has been reported that IFN-mediated in-
duction of apoptosis in IFN-sensitive melanoma cell lines oc-
curs much later, by about 48 h of IFN- treatment.(6,29) Fur-
thermore, our assays for cytotoxicity, based on assaying reporter
enzyme levels of cell supernatants, showed that IFN- treat-
ment (for up to 48 h) did not significantly alter the release of
luciferase activity (Fig. 3). Thus, the experimental results from
PI staining and supernatant activity assays, when considered to-
gether, rule out the possibility that the observed IFN--medi-
ated changes in luciferase activity were caused by compromised
cell membrane permeabilization or associated cytotoxic effects
of IFN.
The type I IFN-mediated reduction in levels of luciferase ac-
tivity were also unlikely to be mediated by effects of IFN at the
transcriptional level. With no difference in luciferase transcript
levels detected between IFN-treated and untreated cells (Fig.
4C,D), it was concluded that type I IFN-mediated reduction in
levels of luciferase activity was most probably mediated by
events occurring at the posttranscriptional level. In addition, the
inhibition of luciferase activity was unlikely to be the result of
differences in the promoters controlling the reporter genes used
in this study. Thus, the firefly luciferase and GFP reporter
genes, both under the control of the EF-1 promoter, both were
not inhibited by IFN.
Regulation of protein synthesis is one mechanism that could
explain the observed IFN-mediated inhibition of luciferase ac-
tivity. The effects of IFN treatment on gene expression include
downregulation of genes associated with protein synthesis.(28)
At the posttranscriptional level, it was reported by Guo et al.(15)
that expression of the ISG P56 by IFN- causes inhibition of
overall cellular protein synthesis through inhibition of eukary-
otic initiation factor 3 (eIF3) function in cells. In addition, their
study revealed that cotransfection of cells with a P56 expres-
sion vector and a luciferase reporter construct caused inhibition
of luciferase protein synthesis.(15) Our study provides evidence
for the inhibitory action of IFN- and IFN- on the levels of
both firefly and Renilla luciferase reporter activity expressed in
transfected cells. As type I IFN-mediated reduction in lucifer-
ase activity required an incubation time greater than 8 h, it fol-
lows that suppression of the transfected reporter gene expres-
sion may well be mediated through the de novo synthesis of an
ISG-encoded protein intermediate, such as P56. Our results are
also in agreement with the proposal that type I IFN acts at the
level of luciferase protein synthesis or turnover. Further stud-
ies will be required to determine the precise mechanism of the
type I IFN-mediated reduction in luciferase activity expressed
in transfected cells and whether the effect is mediated by P56
expression or other IFN-regulated activity affecting protein syn-
thesis (for review, see ref. 14).
A further complication with the use of dual-luciferase re-
porter assays was revealed when the effects of increasing the
amounts of reporter DNA transfected were examined in both
the 96-well and 24  2 ml-well format (Figs. 5 and 6). Thus,
an inhibitory effect was obtained when higher quantities
(
50–100 ng) of reporter DNA were used to transfect cells in
dose-response analyses, whereby levels of luciferase activity
expressed became significantly reduced. This inhibition asso-
ciated with the use of excessive amounts of reporter vectors
was independent of the type of promoter or luciferase reporter
gene expressed, whether Renilla or firefly. A possible expla-
nation for this inhibition could be that transfection with in-
creasing amounts of plasmid DNA causes autogenous expres-
sion of IFNs. For example, CaPO4 DNA precipitates were
shown to induce IFN production in transfected cells,(30) and ac-
tivation of toll-like receptors (TLRs) by double-stranded vec-
tor DNA could induce IFN production.(31) In addition, liposo-
mal transfection reagents themselves have been reported to
induce IFN production.(32) As we have highlighted in the pres-
ent study, the IFN produced by transfecting cells could then
lead to inhibition in expression of luciferase activity, although
further studies would be required to examine this possibility.
With respect to sensitivity of detection and responsiveness
of genes to type I IFNs, there is increasing growth in the wealth
of array data investigating the role of IFNs in gene regulation.
Hence, an increasing amount of focus has been placed on IFN
signaling and the investigation of IFN target genes in a variety
of cell models. As many of the genes identified in this way
show small but biologically significant (2-fold) differences in
gene expression (compared with untreated cells), understand-
ing the broad effects of IFNs on selective posttranslational pro-
cessing is essential to understanding how gene expression data
apply to gene function in specific cell systems, such as cancer
biology, where only small differences in expression can have
considerable effects on cell behavior. Thus, understanding how
to apply reporter gene assays in the context of low levels of re-
sponse becomes highly significant when validating existing cell
signaling pathways and their relevance to pathology. In our
study, the levels of IFN-mediated induction of the ISG15-luc
reporter in the assay were very significant at 20-fold (Fig.
4A,B), and, therefore, the inhibitory effects of using 1 g DNA
in this dual-reporter assay was not found to affect the outcome.
At these levels of induction, the combined inhibitory effect of
DNA and IFN actually would cause an underestimation of the
fold response to IFN.
The differences in the extent of type I IFN affecting the three
different reporter genes indicate that IFN-mediated regulation
occurred by a selective rather than by a general mechanism,
whereby total cellular protein synthesis was inhibited. In this
event, translational regulation by type I IFN would be occur-
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ring in a targeted mRNA-specific manner (for review, see ref.
33). Thus, the present model system could form a useful basis
for further analysis of the effects of type I IFNs on the selec-
tive transcription/translation coupling of the ISGs.
In summary, our study raises a number of limitations and
complications associated with the use of dual-luciferase reporter
gene systems and the analysis of genetic regulation of type I
IFN-sensitive genes. The evidence supports a direct inhibitory
effect of type I IFNs on the expression of both firefly lucifer-
ase and Renilla luciferase activity in studies where these trans-
fection reporter assay systems are employed. Caution must be
applied when interpreting data from studies of IFN-responsive
gene regulation where luciferase reporter systems are used.
Therefore, based on the information provided here, it should be
possible to design reporter assays providing for greater accu-
racy of results in situations where use of cytokines or normal-
ization of the data is important.
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